Literature DB >> 8891141

In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.

O Vidalin1, M E Major, B Rayner, J L Imbach, C Trépo, G Inchauspé.   

Abstract

We have explored different domains within the hepatitis C virus (HCV) 5' noncoding region as potential targets for inhibition of HCV translation by antisense oligodeoxynucleotides (ODNs). Inhibition assays were performed with two different cell-free systems, rabbit reticulocyte lysate and wheat germ extract, and three types of chemical structures for the ODNs were evaluated: natural phosphodiesters (beta-PO), alpha-anomer phosphodiesters (alpha-PO), and phosphorothioates (PS). A total of six original ODNs, displaying sequence-specific inhibition ranging from 62 to 96%, that mapped in the pyrimidine-rich tract (nucleotides [nt] 104 to 127) and in the initiator AUG codon (nt 338 to 357) were identified. Two ODNs, which were targeted at the initiatory AUG (nt 341 to 367 and 351 to 377) and which had been previously described as active against genotype 1b and 2a sequences, were shown to exhibit inhibition of expression (> 95%) of a type 1a sequence. Control experiments with the irrelevant chloramphenicol acetyltransferase sequence as a marker and randomized ODNs demonstrated that levels of inhibition associated with the use of PS compounds (of as much as 94%) were mainly due to nonspecific effects. Both alpha- and beta-PO ODNs were found equally active, and no difference could be seen in the activity of beta-PO when it was tested in either rabbit reticulocyte lysate or wheat germ extract, suggesting that RNase H-independent mechanisms may be involved in the inhibitions observed. However, specific RNA cleavage products generated from beta-PO inhibition experiments could be identified, indicating that, with these compounds, control of translation also involves RNase H-dependent mechanisms. This study further delimits the existence of favorable target sequences for the action of ODNs within the HCV 5' noncoding region and indicates the possibility of using nuclease-resistant alpha-PO compounds in cellular studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891141      PMCID: PMC163531     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

1.  alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition.

Authors:  C Gagnor; J R Bertrand; S Thenet; M Lemaître; F Morvan; B Rayner; C Malvy; B Lebleu; J L Imbach; C Paoletti
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

4.  Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo.

Authors:  S K Jang; M V Davies; R J Kaufman; E Wimmer
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

5.  Inhibition of rabbit globin mRNA translation by sequence-specific oligodeoxyribonucleotides.

Authors:  K R Blake; A Murakami; P S Miller
Journal:  Biochemistry       Date:  1985-10-22       Impact factor: 3.162

6.  Interaction of polypyrimidine tract-binding protein with the 5' noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation.

Authors:  N Ali; A Siddiqui
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

8.  alpha-Oligodeoxynucleotide stability in serum, subcellular extracts and culture media.

Authors:  T A Bacon; F Morvan; B Rayner; J L Imbach; E Wickstrom
Journal:  J Biochem Biophys Methods       Date:  1988-08

9.  alpha-DNA II. Synthesis of unnatural alpha-anomeric oligodeoxyribonucleotides containing the four usual bases and study of their substrate activities for nucleases.

Authors:  F Morvan; B Rayner; J L Imbach; S Thenet; J R Bertrand; J Paoletti; C Malvy; C Paoletti
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

10.  An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5' noncoding region.

Authors:  C Wang; S Y Le; N Ali; A Siddiqui
Journal:  RNA       Date:  1995-07       Impact factor: 4.942

View more
  5 in total

1.  Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.

Authors:  Peter A C 't Hoen; Ruud Out; Jan N M Commandeur; Nico P E Vermeulen; F H D van Batenburg; Muthiah Manoharan; Theo J C van Berkel; Erik A L Biessen; Martin K Bijsterbosch
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

2.  Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.

Authors:  Jan Krönke; Ralf Kittler; Frank Buchholz; Marc P Windisch; Thomas Pietschmann; Ralf Bartenschlager; Michael Frese
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation.

Authors:  Béatrice Tallet-Lopez; Lydia Aldaz-Carroll; Sandrine Chabas; Eric Dausse; Cathy Staedel; Jean-Jacques Toulmé
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

4.  In vitro inhibition of hepatitis C virus by antisense oligonucleotides in PBMC compared to hepatoma cells.

Authors:  Samar Samir Youssef; Ahmed Mohamed Fahmy; Moataza Hassan Omran; Amr Saad Mohamed; Mohamed Ali El Desouki; Mostafa K El-Awady
Journal:  Biomed Res Int       Date:  2014-06-01       Impact factor: 3.411

5.  Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant.

Authors:  H Zhang; R Hanecak; V Brown-Driver; R Azad; B Conklin; M C Fox; K P Anderson
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.